Want to know more? Just complete the form below.
Copyright © 2023 ZOLL Itamar. All rights reserved. WatchPAT and PAT are trademarks or registered trademarks of ZOLL Itamar, a subsidiary of ZOLL Medical Corporation, in the United States and/or other countries. All other trademarks are the property of their respective owners.
References: 1. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364-367. 2. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;144(3):e56-e67. 3. Højager A, Schoos MM, Tingsgaard PK, Bock TG, Homøe P. et al. Prevalence of silent atrial fibrillation and cardiovascular disease in patients with obstructive sleep apnea. Sleep Med. 2022;100:534-541. doi: 10.1016/j.sleep.2022.10.002 4. Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142-1147. doi: 10.1016/j.amj-card.2013.05.063 5. Shukla A, Aizer A, Holmes D, et al. Effect of obstructive sleep apnea treatment on atrial fibrillation recurrence: a meta-analysis. JACC Clin Electrophysiol. 2015;1(1-2):41-51. doi:10.1016/j.jacep.2015.02.014 6. Pillar G, Berall M, Berry RB, et al. Detection of common arrhythmias by the Watch-PAT: expression of electrical arrhythmias by pulse recording. Nat Sci Sleep. 2022;14:751-763. doi: 10.2147/NSS.S359468